Infectious Disease

More links

• 🔗Pro-B-Type Natriuretic Peptide Kinetics across Pre-, Index, and Post-Acute COVID-19 in Hospitalized Acute on Chronic Heart Failure Patients: A Learning Health System Science InitiativeWojitas, C., Vargas, I., Taylor, R., Rosario, M., Khurana, A., Hamad, K. & Heibel, R. (2024). Abstract 4144997: Abstract 4144997: Pro-B-Type Natriuretic Peptide Kinetics across Pre-, Index, and Post-Acute COVID-19 in Hospitalized Acute on Chronic Heart Failure Patients: A Learning Health System Science Initiative. Circulation, 150. https://doi.org/10.1161/circ.150.suppl_1.4144997
• 🔗 Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumoniaMabrey, F. L., Nian, H., Yu, C., Barnes, E. M., Malhotra, U., Mikacenic, C., Goldstein, J., O'Mahony, D. S., Garcia-Diaz, J., Finn, P., Voelker, K., Morrell, E. D., Self, W. H., Becker, P. M., Martin, T. R., & Wurfel, M. M. (2023). Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia. EBioMedicine, 93, 104667. https://doi.org/10.1016/j.ebiom.2023.104667
• 🔗 Longitudinal Characterization of Presentation Clinical Traits in Patients During Index and at Least One Readmission Post-Acute COVID-19Sia, J. E. D.; Idogun, P.; Patel, D.; Hamad, K.; Wiese-Rometsch, W..Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine. (2022). Journal of General Internal Medicine, 37(S2), 129–664. https://doi.org/10.1007/s11606-022-07653-8
• 🔗 Progression Risk Assessment in Hospitalized COVID-19 Patients with Extant Heart Failure: Multiple Chronic Conditions Matter Burns K, Patel D, Whiteside Z, Malik B, Thompson R, Villasmil R, Hamad KM, Wiese- Rometsch W: “Progression Risk Assessment in Hospitalized COVID-19 Patients with Extant Heart Failure: Multiple Chronic Conditions Matter”. American Journal of Respiratory and Critical Care Medicine, Volume 205, May 2022. 1.
• 🔗 COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida.Sia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
• 🔗 Comparing Outcomes in COVID-19 Patients Who Received Standard, Intermediate, or Treatment Dose Enoxaparin and Underwent Intensive CareAbstracts from the 2022 Annual Meeting of the Society of General Internal Medicine. (2022). Journal of General Internal Medicine, 37(S2), 129–664. https://doi.org/10.1007/s11606-022-07653-8
• 🔗 Covid-19 patients expressed distinct clinical trait signatures at index hospitalization across the four SARS-COV-2 pandemic waves in Florida.Sia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
• 🔗 Corticosteroid treatment response in hospital/zed covid-19 patientsWilliams, Stephanie1; Lattanzio, Natalia1; Walo, Richard1; Hamad, Karen2; Wiese-Rometsch, Wilhelmine1; Seaman, Joseph1. 207: CORTICOSTEROID TREATMENT RESPONSE IN HOSPITALIZED COVID-19 PATIENTS. Critical Care Medicine 50(1):p 87, January 2022. | DOI: 10.1097/01.ccm.0000807152.48556.8a
• 🔗 Prediction of Progression to Critical Illness in Heart Failure Patients Hospitalized with COVID-19: Multiple Chronic Conditions MatterK. Burns, R. Walo, D. Patel, Z. Whiteside, B. Malik, R. Thompson, K. Baez Rodriguez, R. Villasmil, Q. Abdelal, K. Hamad, R. Heibel, W. Wiese-Rometsch Prediction of Progression to Critical Illness in Heart Failure Patients Hospitalized with COVID19: Multiple Chronic Conditions Matter Am J Respir Crit Care Med 2022;205:A4294
• 🔗 COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida.Sia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
• 🔗 Clinicopathophysiologic traits driving progression to critical illness in hospitalized COVID-19 patients with heart failureVillasmil R, Pierce, D, Abdelal Q, Burns Katherine, Whiteside Z, Malik B, Lorenzo C, Patel D, Wiese-Rometsch W. Clinicopathophysiologic traits driving progression to critical illness in hospitalized COVID-19 patients with heart failure. Sarasota Memorial Hospital New Knowledge & Innovation Conference; May 2022.
• 🔗 COVID- 19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in FloridaSia, J. E., Idogun, P., Patel, D., Motie, I., Hamad, K., Geary, M., Seaman, J., & Wiese-Rometsch, W. (2022). COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalization Across the Four SARS-CoV-2 Pandemic Waves in Florida. In C14. BURNOUT, DISPARITIES, AND OUTCOMES OF THE COVID-19 PANDEMIC (1–261, pp. A3698–A3698). American Thoracic Society. https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3698
• 🔗 Longitudinal clinical traits of Heart Failure Patients Readmitted Post-COVID-19 Index Hospitalization.Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine. J GEN INTERN MED 37 (Suppl 2), 129–664 (2022). https://doi.org/10.1007/s11606-022-07653-8
• 🔗 Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine AdministrationIdogun, P. O., Ward, M. C., Teklie, Y., Wiese-Rometsch, W., & Baker, J. (2021). Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration. Cureus, 13(5), e14853. https://doi.org/10.7759/cureus.14853
• 🔗 Personalized baseline wrist stratification in hospitalized adult patients with COVID-19: Patient-similarity-based data sciences sheds some light.LATTANZIO, N., ACOSTA, C., VILLASMIL, R., ALKAYALI, T., GEORGE, J., TEKLIE, Y., WILLIAMS, S., STEWART, A., GRIMES, C., GEARY, M., HAMAD, K., WIESE-ROMETSCH, W., GORDILLO, M., & SEAMAN, J. (2021). PERSONALIZED BASELINE RISK STRATIFICATION IN HOSPITALIZED ADULT PATIENTS WITH COVID-19: PATIENT-SIMILARITY-BASED DATA SCIENCE SHEDS SOME LIGHT. Chest, 160(4), A1078–A1079. https://doi.org/10.1016/j.chest.2021.07.998
• 🔗 To "Mask" or "Not-To-Mask" for COV/0-19 Protection?Teklie Y & Beidas S. (2021) To "Mask" or "Not-To-Mask" for COV/0-19 Protection? J Oral Health Dent, 4(3): 353- 355.
• 🔗 Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 MortalityPrecious Idogun, John Sia, Mindy Ward, Dillan Patel, Wilhelmine Wiese-Rometsch, Anjan J. Patel; Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model. Blood 2021; 138 (Supplement 1): 2967. doi: https://doi.org/10.1182/blood-2021-151849
• 🔗 Effectiveness of COVID- 19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization with SARS CoV-2 InfectionLattanzio, N., Acosta-Diaz, C., Villasmil, R. J., Kirkland, Z., Bass, C., Yenari, S., Conte, J., Dawkins, K., Fonseca, T., Grimes, C., Stewart, A., Geary, M. E., Vore, H., Hamad, K., Wiese-Rometsch, W., Fiorica, J., Gordillo, M., Mercado, R., & Voelker, K. (2021). Effectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 Infection. Cureus, 13(7), e16746. https://doi.org/10.7759/cureus.16746